2013
DOI: 10.1016/j.jlumin.2012.10.044
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of 6-mercaptopurine binding to bovine serum albumin and its displacement from the binding sites by quercetin and rutin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
22
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 52 publications
(22 citation statements)
references
References 32 publications
0
22
0
Order By: Relevance
“…As it has been mentioned previously, ALP possesses intrinsic fluorescence arising from Trp, Tyr and Phe residues. The particularities of Tyr and Trp residues in different environmental conditions can be investigated by setting the excitation and emission wavelength interval (Δλ) to 15 and 60 nm, respectively (Ehteshami et al 2013). The effects of heating on ALP synchronous fluorescence spectra are shown in Fig.…”
Section: Synchronous Spectrummentioning
confidence: 99%
“…As it has been mentioned previously, ALP possesses intrinsic fluorescence arising from Trp, Tyr and Phe residues. The particularities of Tyr and Trp residues in different environmental conditions can be investigated by setting the excitation and emission wavelength interval (Δλ) to 15 and 60 nm, respectively (Ehteshami et al 2013). The effects of heating on ALP synchronous fluorescence spectra are shown in Fig.…”
Section: Synchronous Spectrummentioning
confidence: 99%
“…Changes of polarity around the chromophore molecule can be explored by measurement of the possible shift in the maximum emission wavelength (Bi et al 2012). Therefore, the heat-induced changes in Trp and Tyr microenvironment were obtained by setting the excitation and emission wavelength interval (Δλ) to 60 and 15 nm, respectively (Ehteshami et al 2013). Synchronous fluorescence spectrum (SFS) at Δλ of 60 nm for β-Lg (a) and β-Lg-LA (b) are shown in Fig.…”
Section: Synchronous Fluorescence Spectroscopymentioning
confidence: 99%
“…6-Mercaptopurine (6-MP), is derived from the prodrugazathiopurine that is non-enzymatically converted to 6-MP in tissues, is a purine analogue which has antineoplastic and immunosuppressant properties [1]. Since its approval as an antitumour drug from Food and Drug Administration (FDA) in 1953 [2], it has been widely used in the treatment of acute lymphoblastic leukemia (ALL), rheumatological disorders, prevention of rejection following organ transplantation and inflammatory diseases [3].…”
Section: Introductionmentioning
confidence: 99%
“…For instance, incorporation of 6-TG induces cytotoxicity mediated via G2/M and/or S phase arrest [7,8]. However, 6-MP undergoes a complex biotransformation by XO (Xanthine oxidase) and TPMT (thiopurine S methyl transferase) which limits its bioavailability and leads to incomplete and variable bioavailability (about 16-50%) [1,9], short plasma half-life (0.5-1.5 h) [10], moderate plasma protein binding (19-30%) [11] and narrows therapeutic index which in turn results in plummeting chemotherapeutic effect and life-threatening toxicity, mainly in the form of myelosuppression [12,3].…”
Section: Introductionmentioning
confidence: 99%